Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019;51(4):299-305.
doi: 10.5114/ait.2019.88104.

Sepsis diagnosis and monitoring - procalcitonin as standard, but what next?

Magdalena Mierzchała-Pasierb  1 , Małgorzata Lipińska-Gediga  2   3
Affiliations
Free article
Review

Sepsis diagnosis and monitoring - procalcitonin as standard, but what next?

Magdalena Mierzchała-Pasierb et al. Anaesthesiol Intensive Ther. 2019.
Free article

Abstract

Sepsis is a life-threatening organ dysfunction caused by a systemic altered host response to infection. According to the newest guidelines the sepsis treatment should be personalized and based on an approach specified by use of biomarkers to tailor therapy to each patient's needs. The main features of such biomarkers should be high specificity, sensitivity and ability to monitor the progress of sepsis. There is limited application of procalcitonin (PCT), C-reactive protein (CRP) and interleukin-6 (IL-6) for reaching this target, because of their secretion during non-infectious processes. The purpose of this review was to introduce four biomarkers, i.e. kallistatin, testican-1, presepsin and mid-regional pro-adrenomedullin, and compare their usefulness in diagnosing sepsis with PCT, CRP and IL-6.

Keywords: biomarkers; monitoring; mortality; sepsis.

PubMed Disclaimer